酒精性肝病相关慢加急性肝衰竭:机制、动态评估与精准管理OA
Alcohol-related liver disease-associated acute-on-chronic liver failure:Mechanisms,dynamic assessment,and precise management
慢加急性肝衰竭(ACLF)是慢性肝病急性恶化期的高病死率综合征,以系统性炎症驱动的多器官功能障碍为核心特征.酒精性肝病相关慢加急性肝衰竭(ALD-ACLF)因肠道微生态失衡、内毒素易位及炎症反应放大更为突出,常伴随较高的继发感染风险和肝外器官受累,具有明显的病因学与临床特异性.本综述系统梳理ALD-ACLF的概念边界、病理生理机制、动态预警与预后评估进展,重点评述风险分层及临床管理决策要点,并探讨代谢功能障碍合并酒精相关肝病双重打击表型对ALD-ACLF风险分层的潜在影响.提示临床应进一步强化病因导向的早期识别、动态分层、诱因控制和干预前移,以期为该类患者的精准评估及个体化干预提供参考.
Acute-on-chronic liver failure(ACLF)is a high-mortality syndrome that develops during the acute deterioration of chronic liver disease and is characterized by multiple organ dysfunction driven by systemic inflammation.Due to gut microbiota dysbiosis,endotoxin translocation,and amplified inflammatory responses,alcohol-related liver disease-associated ACLF(ALD-ACLF)is more pronounced and is often accompanied by a high risk of secondary infection and extrahepatic organ involvement,thereby exhibiting distinct etiological and clinical characteristics.This article systematically reviews the advances in the definitional boundaries,pathophysiological mechanisms,dynamic early warning,and prognostic assessment of ALD-ACLF,elaborates on risk stratification and key issues in clinical management,and discusses the potential impact of the dual-hit phenotype of metabolic dysfunction and alcohol-related liver disease on risk stratification in ALD-ACLF.This article also highlights the need to further strengthen etiology-oriented early identification,dynamic stratification,control of predisposing factors,and earlier intervention,in order to provide a reference for the precise assessment and individualized intervention of these patients.
艾娜;崔怀宁;方晓慧;柳涛;高沿航
吉林大学第一医院肝胆胰内科,传染病与病原生物学中心,长春 130021||吉林省肝脏代谢重点实验室,长春 130021||中国-新加坡"一带一路"肝脏病学研究联合实验室,长春 130021吉林大学第一医院肝胆胰内科,传染病与病原生物学中心,长春 130021||吉林省肝脏代谢重点实验室,长春 130021||中国-新加坡"一带一路"肝脏病学研究联合实验室,长春 130021吉林大学第一医院肝胆胰内科,传染病与病原生物学中心,长春 130021||吉林省肝脏代谢重点实验室,长春 130021||中国-新加坡"一带一路"肝脏病学研究联合实验室,长春 130021吉林大学第一医院肝胆胰内科,传染病与病原生物学中心,长春 130021||吉林省肝脏代谢重点实验室,长春 130021||中国-新加坡"一带一路"肝脏病学研究联合实验室,长春 130021吉林大学第一医院肝胆胰内科,传染病与病原生物学中心,长春 130021||吉林省肝脏代谢重点实验室,长春 130021||中国-新加坡"一带一路"肝脏病学研究联合实验室,长春 130021
慢加急性肝功能衰竭肝疾病,酒精性疾病管理
Acute-On-Chronic Liver FailureLiver Diseases,AlcoholicDisease Management
《临床肝胆病杂志》 2026 (8)
1755-1760,6
国家自然科学基金(U24A20654)吉林省自然科学基金自由探索重点项目(YDZJ202401427ZYTS)吉林省肝脏代谢重点实验室(YDZJ202502CXJD002)吉林省全国重点实验室(学科类)重大专项(BRI202602001GH)国家重点研发计划(2024YFE0213800)National Natural Science Foundation of China(U24A20654)Natural Science Foundation for Self-Exploration Research of Jilin Province(YDZJ202401427ZYTS)Jilin Provincial Key Laboratory of Metabolic Liver Diseases(YDZJ202502CXJD002)Major Special Project of the National Key Laboratory of Jilin Province(BRI202602001GH)National Key Research and Development Program of China(2024YFE0213800)
评论